Artificial Liver Center, Beijing Youan Hospital, Capital Medical University, 8 Xitoutiao, Youwai Street, Beijing, 100069, China.
Calgary Liver Unit, Division of Gastroenterology and Hepatology, Department of Medicine, Cumming School of Medicine, University of Calgary 6D21, Teaching, Research and Wellness Building, 3280 Hospital Drive N.W, Calgary, AB, T2N 4Z6, Canada.
Virol J. 2017 Oct 24;14(1):203. doi: 10.1186/s12985-017-0870-x.
The pathogenesis of acute-on-chronic liver failure (ACLF) in chronic hepatitis B (CHB) is not well understood. The aim of this study was to investigate whether there is an association between HBV polymerase (P)/overlapping surface (S) gene and basal core promoter (BCP)/precore (PC) variants and development of ACLF in CHB.
Two CHB patient cohorts were compared: (i) ACLF (N = 12) (11/12 M, median age 52 yrs., 5/9 genotype C, 6/12 HBeAg+), (ii) 27 treatment native CHB carriers (15/27 M, median age 44 yrs., 9 genotype B, 10 genotype C, 1 genotype A, 5 genotype D, 2 genotype E). Clonal sequencing of PCR-amplified HBV P/S and BCP/PC gene fragments was done and HBV diversity, frequency of immune escape (IE) and drug resistance (DR) mutations and mutations in BCP/PC gene (G1896A and A1762T/G1764A), were compared between each group.
Our data showed the incidence of IE and clusters of mutations in the HBV S region was significantly greater in ACLF patients vs. treatment naïve CHB patients (p < 0.05). Additionally, a significantly higher frequency of G1896A and A1762T/G1764A mutations were found in HBeAg negative than in ACLF patients (p < 0.0001).
In our study, ACLF was not associated with a specific genomic mutation. However, higher frequency of IE mutations along with various mutations clustering in the HBV S region could contribute to or be an outcome of ACLF in CHB infection. (words 226).
慢性乙型肝炎(CHB)急性肝衰竭(ACLF)的发病机制尚不清楚。本研究旨在探讨乙型肝炎病毒聚合酶(P)/重叠表面(S)基因与基本核心启动子(BCP)/前核心(PC)变异是否与 CHB 患者 ACLF 的发生有关。
比较了两个 CHB 患者队列:(i)ACLF(N=12)(11/12 例男性,中位年龄 52 岁,5/9 基因型 C,6/12 HBeAg+),(ii)27 例未经治疗的 CHB 携带者(15/27 例男性,中位年龄 44 岁,9 基因型 B,10 基因型 C,1 基因型 A,5 基因型 D,2 基因型 E)。对 PCR 扩增的 HBV P/S 和 BCP/PC 基因片段进行克隆测序,比较各组间 HBV 多样性、免疫逃逸(IE)和耐药(DR)突变频率以及 BCP/PC 基因(G1896A 和 A1762T/G1764A)突变。
我们的数据显示,IE 发生率和 HBV S 区突变簇在 ACLF 患者中明显高于治疗初治 CHB 患者(p<0.05)。此外,在 HBeAg 阴性患者中发现 G1896A 和 A1762T/G1764A 突变的频率明显高于 ACLF 患者(p<0.0001)。
在本研究中,ACLF 与特定的基因组突变无关。然而,较高的 IE 突变频率以及 HBV S 区各种突变簇的形成可能导致或成为 CHB 感染中 ACLF 的结果。(226 个单词)